This review has identified multiple considerations, highlighting the need to identify patients highest at risk of ureteric stenosis. There is also a need to recognize ureters as organs at risk, record dose exposure, and apply dose constraints, all of which set the landscape for allowing dose optimization.
Keyphrases
- locally advanced
- end stage renal disease
- ejection fraction
- rectal cancer
- squamous cell carcinoma
- neoadjuvant chemotherapy
- newly diagnosed
- radiation therapy
- chronic kidney disease
- early stage
- prognostic factors
- peritoneal dialysis
- high glucose
- phase ii study
- diabetic rats
- radiation induced
- patient reported outcomes
- endothelial cells
- open label
- study protocol